查找临床试验
已按「淋巴瘤」检索，对应国际通用词 lymphoma
共找到 610 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:08，每 5 分钟自动同步CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
China
年龄 18 Years – 75 Years
Chinese PLA General Hospital
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
China
年龄 18 Years – 不限
Institute of Hematology & Blood Diseases Hospital, China
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
China
年龄 18 Years – 不限
Dizal Pharmaceuticals
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
China
年龄 3 Years – 21 Years
Chongqing Precision Biotech Co., Ltd
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
United States、Australia、Belgium、Brazil、Canada 等 12 国
年龄 18 Years – 不限
Merck Sharp & Dohme LLC
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
China
年龄 18 Years – 70 Years
The First Affiliated Hospital of Xiamen University
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
China
年龄 1 Year – 18 Years
Sun Yat-sen University
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
China
年龄 65 Years – 不限
Zhejiang Cancer Hospital
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
China
年龄 18 Years – 不限
Nanjing IASO Biotechnology Co., Ltd.
Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma
China
年龄 2 Years – 75 Years
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
China
年龄 18 Years – 70 Years
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
PUMCH Dementia Longitudinal Cohort Study
China
年龄 18 Years – 不限
Peking Union Medical College Hospital